skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: What do you think of the recent developments at Knight Therapeutics Inc? Their New Drug Submission has been accepted for review by Health Canada and they have entered into an exclusive distribution agreement with Ember Therapeutics.GUD seems to have dropped 7% in the last couple days on the news. It seems to me the news was positive but is there something I'm missing? Thank-you for your service.
Read Answer Asked by Bryan on August 07, 2015
Q: Hello Peter & Co,
A follow up on my previous question. SIS is classified as Industrials; is it because of its manufacturing side?
PM is classified as health
Thanks,
Antoine
Read Answer Asked by Antoine on August 06, 2015
Q: Another article on PHM in the Globe and Mail and again you've provided a negative quote which they've included. I'm dissapointed that you are adding to the negative sentiment on this stock which is in your growth portfolio and which many of your members have purchased, especially when the fundamentals of the company are still good.

Read Answer Asked by Carla on August 06, 2015
Q: What are your thoughts on a share purchase at this time? Pozen has a new CEO guiding them who has a stellar reputation for packaging companies as attractive takeover targets.
Read Answer Asked by Gary on August 05, 2015
Q: Hi,
Can you tell me why TRL has been declining lately? Have the fundamentals changed or is this just a case of investors bailing out in a tough market?
Thanks
Read Answer Asked by Rob on August 05, 2015
Q: First I want to say what a great job Peter did today on BBN.I know you are not familiar with a number of US co. but was hoping you might have something on this co.Thanks
Read Answer Asked by jim on August 05, 2015
Q: everyones favorite company, what the just announced press release tell you, does it put the panic to bed. dave
Read Answer Asked by david on August 05, 2015
Q: Hi Peter, thanks for your good comments of PHM on BNN this evening. Indeed, it answered a few questions of mine regarding future acquisitions and financing. You have advised members to do nothing. Now my question is at what point investors can buy additional shares to average down? I normally don't like to average down. However, there is nothing wrong with Its fundamental. Should investors use average down strategy to take advantage of declined price? I see it has great value under a dollar. What's the fair value do you think PHM should be priced at considers its fundamental only? Thank you!
Read Answer Asked by Rebecca on August 05, 2015
Q: Hi 5i Team, Still working on my rebalance after Portfolio Review. Catamaran is now taken over and my HEALTHCARE is CXR 2.9%, GUD, 0.7 and PLI 0.6% total 4.2%. Want to go to 5% and hold CXR, should I increase the other 2 or would you suggest something else? Appreciate your help always.

Ted

Read Answer Asked by Ted on August 04, 2015
Q: I haven't seen a question about Biosyent in a couple of months, it's trading near its 52 week low. You indicated in May the fundamentals looked good, the price is still is dropping possibly due to the sector. I am considering taking a position at this time, please advise your thoughts.
Thanks
Jim
Read Answer Asked by Jim on July 31, 2015
Q: PHM = 24 million shares sold today. 24,000,000 shares BOUGHT today. I bought 2,000 more shares today at $.80. It is now my largest single stock holding at 16,000 shares. Average price $1.07 . Am I the dumb one here?
Read Answer Asked by Bryan on July 30, 2015
Q: I just noticed on insider trading reports for july 28.That Dalsin and Greene were granted 3 million options .Are they not out of the company?Would the new ceo have to approve this.These 2 have more moves than a bucket of minnows.They would make Murray Pezim proud.
Read Answer Asked by glenn on July 29, 2015
Q: PHM just released the statement - PHM Unaware of Any Material Change

LOS ANGELES, CALIFORNIA--(Marketwired - Jul 29, 2015) - Patient Home Monitoring Corp. ("PHM") (TSX VENTURE:PHM), a fast growing and profitable company focused on rolling-up annuity-based healthcare service companies in the US and Canada, at the request of the Investment Industry Regulatory Organization of Canada (IIROC), wishes to confirm that its management is unaware of any material change in PHM's operations that would account for the recent decrease in its stock price.

Hopefully, it will calm down the market a bit. Publish if it help 5i members.
Read Answer Asked by Rebecca on July 29, 2015
Q: This morning Canada Insider shows Dalsin and Greene each granted 3 millions of share option and 4 millions of shares bought @1.36 through acquisition carried out privately. This is consistent with what Dalsin mentioned on conference call. Publish if you think it will help members. Thanks!
Read Answer Asked by Rebecca on July 29, 2015
Q: so everyone's favorite company took it on the chin and convalo and inspira went down in sympathy with phm.
dalsin and greene did everything right and the street loved them, then they made a huge misstep selling shares, not being forthcoming with the market, appointing new ceos, putting some shares into a health fund. The first bad news is never the last bad news.please comment. dave
Read Answer Asked by david on July 29, 2015
Q: Looks like the market is not satisfied with the lack of clarity from PHM regarding insider selling. Do you view this as an overreaction and an opportunity to purchase or a wait and see?
Read Answer Asked by Rudy on July 28, 2015
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!